You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Article metrics

Article menu

This article has a correction. Please see:

Original research
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

 

Online download statistics by month:

Online download statistics by month: September 2022 to September 2024

AbstractFullPdf
Sep 202233632376
Oct 2022306308123
Nov 202217717185
Dec 202212612236
Jan 2023645933
Feb 2023147145115
Mar 202316816060
Apr 202314813959
May 2023206201119
Jun 202318718057
Jul 202312411563
Aug 202313312050
Sep 2023948159
Oct 2023787249
Nov 202312311570
Dec 202312912880
Jan 202411510776
Feb 2024767160
Mar 20247173171
Apr 2024918892
May 202426225953
Jun 2024757167
Jul 202411811561
Aug 2024716660
Sep 2024686247
Total349333511821